Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRIZANLIZUMAB-TMCA: 1,130 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,130
Total FAERS Reports
37 (3.3%)
Deaths Reported
435
Hospitalizations
1,130
As Primary/Secondary Suspect
13
Life-Threatening
26
Disabilities
Prescription
Status

FDA Application: 761128 ·

First Report: 2019 · Latest Report: 20250509

What Are the Most Common CRIZANLIZUMAB-TMCA Side Effects?

#1 Most Reported
Pain
313 reports (27.7%)
#2 Most Reported
Sickle cell anaemia with crisis
263 reports (23.3%)
#3 Most Reported
Back pain
125 reports (11.1%)

All CRIZANLIZUMAB-TMCA Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Pain 313 27.7% 5 138
Sickle cell anaemia with crisis 263 23.3% 2 202
Back pain 125 11.1% 1 60
Infusion related reaction 110 9.7% 0 46
Arthralgia 81 7.2% 4 36
Pain in extremity 75 6.6% 2 43
Drug ineffective 74 6.6% 0 20
Chest pain 63 5.6% 0 41
Pyrexia 62 5.5% 3 43
Nausea 57 5.0% 0 9
Fatigue 55 4.9% 1 20
Headache 54 4.8% 0 22
Haemoglobin decreased 39 3.5% 1 29
Acute chest syndrome 37 3.3% 2 30
Product storage error 35 3.1% 0 2
Pruritus 34 3.0% 0 11
Dyspnoea 31 2.7% 2 18
Illness 27 2.4% 1 14
Malaise 26 2.3% 0 10
Pneumonia 25 2.2% 0 20

Who Reports CRIZANLIZUMAB-TMCA Side Effects? Age & Gender Data

Gender: 63.6% female, 36.4% male. Average age: 29.9 years. Most reports from: US. View detailed demographics →

Is CRIZANLIZUMAB-TMCA Getting Safer? Reports by Year

YearReportsDeathsHosp.
2019 4 0 3
2020 164 3 84
2021 110 9 57
2022 89 3 56
2023 27 3 23
2024 35 0 28
2025 6 0 6

View full timeline →

What Is CRIZANLIZUMAB-TMCA Used For?

IndicationReports
Sickle cell disease 556
Product used for unknown indication 333
Sickle cell anaemia with crisis 216
Sickle cell anaemia 23
Thalassaemia sickle cell 8

CRIZANLIZUMAB-TMCA vs Alternatives: Which Is Safer?

CRIZANLIZUMAB-TMCA vs CRIZOTINIB CRIZANLIZUMAB-TMCA vs CROFELEMER CRIZANLIZUMAB-TMCA vs CROMOLYN CRIZANLIZUMAB-TMCA vs CROTALIDAE POLYVALENT IMMUNE FAB CRIZANLIZUMAB-TMCA vs CUBICIN CRIZANLIZUMAB-TMCA vs CUPRIC CRIZANLIZUMAB-TMCA vs CUPRIC ANHYDROUS CRIZANLIZUMAB-TMCA vs CUPRIC\FOLIC ACID\NIACIN\ZINC CRIZANLIZUMAB-TMCA vs CX-024414 CRIZANLIZUMAB-TMCA vs CYAMEMAZINE

Official FDA Label for CRIZANLIZUMAB-TMCA

Official prescribing information from the FDA-approved drug label.